Tirzepatide or semaglutide · physician-titrated
GLP-1 with a doctor in the loop.
Tirzepatide and semaglutide — the dual GIP/GLP-1 and GLP-1 receptor agonists now occupying half the wellness conversation — prescribed by a physician who actually titrates your dose week-over-week instead of dumping you on the standard ladder. Most users get this from compounding mills that don't track anything. We track everything.
For the executive who wants the result, not the GI side-effects nobody warned them about.
Licensed physicians
8-state coverage
503B compounding pharmacy
FDA-registered, cGMP-compliant
Cold-chain validated
2–8°C door-to-door
Refundable consult
If the physician declines
First month bundle
$399
Consult + first month’s prescription. Refills $299/mo · about $13.30/day
- Async consult with a licensed physician
- Compounded tirzepatide or semaglutide (physician selects)
- Weekly cold-chain pen refills
- Conduit pen + 30 pen needles
- In-app titration tracking + side-effect monitoring
- Conduit+ membership for the duration
Refundable consult if the physician declines.
Why people pick this
“Three months in, down 18 pounds, no nausea past week 2 because the physician slowed my titration when I asked. That conversation doesn't happen at a compounding mill.”
Conduit Care user · Fat loss protocol
The mechanism, in plain English.
Tirzepatide is a dual GIP/GLP-1 receptor agonist; semaglutide is a GLP-1 agonist alone. Both slow gastric emptying, suppress appetite via central pathways, and improve insulin sensitivity. SURPASS-2 showed tirzepatide outperformed semaglutide for total weight loss at 40 weeks. The titration ladder matters: slow ramps reduce nausea and protein-deficit risk.
- NoteSURPASS-2: tirzepatide produced ~15-22% mean weight loss vs semaglutide ~11% at 40 weeks (Frías et al., NEJM 2021)
- NoteSlow titration (2.5 → 5 → 7.5 mg every 4 weeks for tirzepatide) reduces GI dropout
- NoteLean mass preservation requires adequate protein intake (~1g per lb body weight) and resistance training during the cycle
- NotePlateau or off-cycle weight regain is mitigated by metabolic-rate-protective tapers; physician adjusts
What changes, and when.
01 · Week 1
Cold-chain pen-ready dose arrives. First weekly injection logged.
02 · Week 4
First titration check-in. Most users at 5 mg tirz / 0.5 mg sema by this point.
03 · Week 12
~8–15 lb loss range typical at this dose tier. Plateau decisions made with the physician.
04 · Month 6+
Off-ramp protocol or maintenance dose, depending on goal. Lean mass preserved if protein + training in place.
Three ways to run fat loss.
Do nothing
Status quo.
- · No risk, no result
- · Hope it resolves on its own
- · No data captured
- · $0 / month
Self-source
Research-supply gamble.
- · Unverified source + COA
- · No physician oversight
- · Reconstitute yourself
- · Maybe $100–200 / month
Conduit Care
Pharma-grade.
- · 503B pharmacy + COA
- · Physician-supervised
- · Cold-chain shipped, pen-ready
- · $299/mo refill
The physician
Licensed in your state.
Your case is reviewed asynchronously by a physician licensed in your state of residence. They evaluate your medical history, current medications, and contraindications against the requested protocol. They approve, decline, or request more information. They are accountable for the prescription.
24-hour median response
The pharmacy
503B compounding.
An FDA-registered 503B outsourcing facility fills your prescription. cGMP-compliant production. Lot-tracked vials. USP <797> sterile compounding standards. Validated 2–8°C cold-chain transit from the fill line to your door.
FDA-registered, cGMP-compliant
Before you start.
- How is this different from buying research peptides online?
- A licensed physician reviews your medical history and writes a prescription before anything ships. A 503B compounding pharmacy fulfills the prescription — meaning FDA-registered facility, cGMP-compliant production, validated cold-chain transit. Research-supply sites operate without prescription oversight or pharmacy-grade fulfillment. The product, the process, and the accountability are categorically different.
- How long does the review take?
- Most cases are reviewed within 24 hours. The physician may approve, request more information, or decline based on contraindications. If declined, the consult fee is refunded in full.
- Is this telehealth or in-person?
- Asynchronous telehealth only. You complete an intake form, upload an ID, the physician reviews on their own schedule. No video visit required. You can complete the entire intake in under five minutes and the physician responds in under 24 hours.
- What if I already use insulin syringes and vials?
- You can still use Conduit. The Conduit pen accepts the cold-chain reconstituted vials we ship — no draws, no math. If you prefer to keep using syringes, you can buy the pen separately on /shop. The Conduit app tracks doses either way.
- What states do you ship to?
- Conduit Care is currently live in Texas, Tennessee, Oklahoma, Louisiana, Arizona, Georgia, Florida, and New York. Coverage depends on physician licensure and pharmacy reach. We expand quarterly. If your state isn’t live yet, the waitlist is the fastest way to know when it goes live.
Not a guarantee.
Not for everyone.
- · The reviewing physician determines dose, duration, and eligibility based on your intake. They may decline.
- · Fat loss protocols are not FDA-approved indications for these peptides. Conduit Care operates within compounded- product framework with licensed physician oversight.
- · Outcomes vary. Conduit doesn’t make therapeutic claims; the platform supports adherence and tracking.
- · Consult fee is refundable if the physician declines. Prescription cost is not refundable once filled.
Working on something else?
Ready
Start your fat loss protocol.
A licensed physician reviews in under 24 hours. Refundable if declined.
Conduit products are sterile fluid transfer devices intended for research applications. Conduit Care is a separate asynchronous telehealth service. Not intended for diagnosis, treatment, or prevention of any disease. The Fat loss protocol is not an FDA-approved indication for these peptides; it is a compounded-product framework under licensed physician oversight.